Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Nantkwest, Inc.

NASDAQ: NKHealthcare / Biotechnology / USA
1.26-0.0800-5.97%Vol 294 8491Y Perf -67.18%
Mar 22nd, 2019 16:00
BID1.25 ASK1.26
Open1.37 Previous Close1.34
Pre-Market1.40 After-Trading1.26
 0.06 4.48%  - -%
Target Price
3.50 
Analyst Rating
Hold 3.00
Potencial %
177.78 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
★+     41.26
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)100 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
9.51 
Earnings Date
25th Mar 2019

Today's Price Range

1.251.38

 

52wk Range

0.93004.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
6.78%
3 Months
24.75%
6 Months
-61.82%
1 Year
-67.18%
3 Years
-85.35%
5 Years
-

Name / TickerPriceChg.Chg.%
NK1.26-0.0800-5.97
AAPL191.05-4.0400-2.07
GOOG1 205.50-26.0400-2.11
MSFT117.05-3.1700-2.64
XOM80.48-1.3100-1.60
WFC48.31-1.5500-3.11
JNJ136.91-1.1900-0.86
FB164.34-1.7400-1.05
GE9.98-0.2900-2.82
JPM99.76-3.1100-3.02
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.20
Current Ratio
3.30
Long Term Debt to Total Capital
0.04
Total Debt to Equity
0.05
Interest Coverage
-222.40
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-204 885.00
EBITDA Margin
-184 555.00
Pre-tax Profit Margin
-168 449.00
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
47
Revenue per Share
0.00
Revenue Growth 3 Years
-38.16
Revenue Growth 5 Years
-41.89

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.37-0.3018.92
Q01 2018-0.34-0.35-2.94
Q04 2017--0.31-
Q02 2017-0.32-0.299.38
Q01 2017-0.39-0.3023.08
Q02 2016-0.35-0.41-17.14
Q01 2016-0.24-0.38-58.33
Q03 2015-0.07-0.55-685.71
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.310.00-
12/2018 FY-1.310.00-
3/2019 QR-0.310.00-
12/2019 FY-1.297.86Positive
Next Report Date25th Mar 2019
Estimated EPS Next Report-0.31
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume294 849
Shares Outstanding (in ths.)79 088
Trades Count555
Dollar Volume307 136
Avg. Volume280 023
Avg. Weekly Volume398 532
Avg. Monthly Volume429 223
Avg. Quarterly Volume280 006

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

Bearish Bullish

76%24%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News